Deaths, thromboembolism and effective haemostasis, Total and by reversal agent

Reversal agents for DOACs – a recent meta-analysis

By Saadia Aslam Major bleeding that requires hospitalisation occurs in 2% to 3.5% of patients that take DOACs. Some of these patients may require reversal…

View More Reversal agents for DOACs – a recent meta-analysis
NICE logo

NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation

Key changes: Bleeding risk scoreNew NICE guideline recommends using the ORBIT bleeding risk score but equally recognises that existing bleeding risk scores may still be…

View More NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation